Literature DB >> 17482789

Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.

S Y Kim1, J-L Roh, J S Kim, C H Ryu, J H Lee, K-J Cho, S-H Choi, S Y Nam.   

Abstract

BACKGROUND: The utility of (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in oral cavity cancer has received little attention in a clinician's perspective. We systematically evaluated the clinical roles of FDG PET in patients with oral cavity squamous cell carcinomas (SCCs).
METHODS: Between August 2001 and February 2005, 82 new patients with resectable oral cavity SCCs underwent CT/MRI and FDG PET at initial staging and follow-up. The sensitivity and specificity of CT/MRI and FDG PET for neck metastases were compared with histopathologic reference of 67 patients who underwent neck dissection. The relationships between the maximal standardized uptake value (SUV) of primary tumors and clinicopathologic parameters, such as gender, age, tumor thickness, local invasiveness, T and N categories, tumor-node-metastasis stage, and histological grade, as well as with disease-free survival (DFS), were assessed.
RESULTS: FDG PET was more sensitive than CT/MRI for detecting cervical metastases on a level-by-level basis (38/43 vs. 28/43; P=0.002). Age, T and N categories, tumor thickness (>8mm) and SUV (>5.0) were also significant variables of 3-year DFS in univariate analysis. T category was an independent determinant of DFS in multivariate analysis (P<0.05). During a mean follow-up of 36 months, FDG PET correctly diagnosed locoregional recurrences in 20 patients, distant metastases in six and second cancers in five.
CONCLUSION: FDG PET may have potential roles in initial staging, survival prediction, and the detection of recurrences and second cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482789     DOI: 10.1016/j.ejso.2007.03.015

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  10 in total

1.  A combined analysis of maximum standardized uptake value on FDG-PET, genetic markers, and clinicopathological risk factors in the prognostic stratification of patients with resected oral cavity squamous cell carcinoma.

Authors:  Chun-Ta Liao; Chia-Hsun Hsieh; Wen-Lang Fan; Shu-Hang Ng; Nai-Ming Cheng; Li-Yu Lee; Chuen Hsueh; Chien-Yu Lin; Kang-Hsing Fan; Hung-Ming Wang; Chih-Hung Lin; Chung-Kan Tsao; Chung-Jan Kang; Tuan-Jen Fang; Shiang-Fu Huang; Kai-Ping Chang; Li-Ang Lee; Ku-Hao Fang; Yu-Chien Wang; Lan-Yan Yang; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-06       Impact factor: 9.236

2.  18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis.

Authors:  Peng Xie; Minghuan Li; Hanxi Zhao; Xindong Sun; Zheng Fu; Jinming Yu
Journal:  J Cancer Res Clin Oncol       Date:  2011-01-13       Impact factor: 4.553

3.  Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 Tesla.

Authors:  Julia Fruehwald-Pallamar; Christian Czerny; Marius E Mayerhoefer; Benjamin S Halpern; Christina Eder-Czembirek; Markus Brunner; Matthias Schuetz; Michael Weber; Laura Fruehwald; Andreas M Herneth
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-05       Impact factor: 9.236

Review 4.  Distant metastasis from oral cavity-correlation between histopathology results and primary site.

Authors:  Yuka Uchiyama; Tadashi Sasai; Atsutoshi Nakatani; Hiroaki Shimamoto; Tomomi Tsujimoto; Sven Kreiborg; Shumei Murakami
Journal:  Oral Radiol       Date:  2020-05-28       Impact factor: 1.852

5.  Tumour thickness in oral cancer using an intra-oral ultrasound probe.

Authors:  Wouter L Lodder; Hendrik J Teertstra; Ing B Tan; Frank A Pameijer; Ludi E Smeele; Marie-Louise F van Velthuysen; Michiel W M van den Brekel
Journal:  Eur Radiol       Date:  2010-08-03       Impact factor: 5.315

6.  Associations Between [18F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1α, and p53 in Head and Neck Squamous Cell Carcinoma.

Authors:  Alexey Surov; Hans Jonas Meyer; Anne-Kathrin Höhn; Karsten Winter; Osama Sabri; Sandra Purz
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

7.  Diagnostic value of retrospective PET-MRI fusion in head-and-neck cancer.

Authors:  Denys J Loeffelbein; Michael Souvatzoglou; Veronika Wankerl; Julia Dinges; Lucas M Ritschl; Thomas Mücke; Anja Pickhard; Matthias Eiber; Markus Schwaiger; Ambros J Beer
Journal:  BMC Cancer       Date:  2014-11-19       Impact factor: 4.430

8.  Total lesion glycolysis in oral squamous cell carcinoma as a biomarker derived from pre-operative FDG PET/CT outperforms established prognostic factors in a newly developed multivariate prediction model.

Authors:  Gerrit Spanier; Daniela Weidt; Dirk Hellwig; Johannes K H Meier; Torsten E Reichert; Jirka Grosse
Journal:  Oncotarget       Date:  2021-01-05

9.  Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography, computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with pathologically positive neck lymph node.

Authors:  Eunjin Jwa; Sang-Wook Lee; Jae-Seung Kim; Jin Hong Park; Su Ssan Kim; Young Seok Kim; Sang Min Yoon; Si Yeol Song; Jong Hoon Kim; Eun Kyung Choi; Seung Do Ahn
Journal:  Radiat Oncol J       Date:  2012-12-31

10.  Associations between 18F-FDG-PET, DWI, and DCE Parameters in Patients with Head and Neck Squamous Cell Carcinoma Depend on Tumor Grading.

Authors:  Leonard Leifels; Sandra Purz; Patrick Stumpp; Stefan Schob; Hans Jonas Meyer; Thomas Kahn; Osama Sabri; Alexey Surov
Journal:  Contrast Media Mol Imaging       Date:  2017-10-19       Impact factor: 3.161

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.